SAN JOSE, CA — Molecular Devices, LLC., a
leading provider of high-performance life science solutions and a company of
Danaher Corporation (NYSE:DHR), has launched its SpectraMax® Mini Multi-Mode Microplate Reader, a compact and economical solution designed to
save researchers benchtop space and budget. Built on the company’s nearly four
decades of experience delivering high-performance microplate reader technology
to the market, the SpectraMax Mini reader is robust enough to meet a lab’s core
microplate reader needs, while its compact size is ideal for integration into a
large workstation with multiple instruments. “We created the SpectraMax Mini
reader for budget-conscious labs in need of a versatile, high-performing
multi-mode solution,” said Susan Murphy, president of Molecular Devices. “The
new reader joins our extensive SpectraMax line of user-friendly microplate
readers—the industry’s most cited brand—to help scientists from academic labs
to fast-paced biotechnology organizations advance their research.” The user-upgradeable SpectraMax
Mini reader features up to three modes of detection for UV-Visible absorbance,
fluorescence, and luminescence, allowing for key applications like reporter gene expression, ELISA, DNA and protein quantitation, cell viability, and more. Integrated with the system is the protocol
control and data analysis software, SoftMax® Pro Software, to enable rapid data
generation and analysis. The
SpectraMax Mini reader offers customers: The SpectraMax Mini reader is now
available globally to advance research around the world. To learn more, visit www.moleculardevices.com/newspectramaxmini.The
SpectraMax® is a compact and economical solution designed to save researchers
benchtop space and budget